Giancarlo Castaman

Ospedale San Bortolo

Papers

1

Total Citations

30

H-Index

1

About

Giancarlo Castaman is a leading hematologist whose research has fundamentally advanced the understanding and diagnosis of von Willebrand disease (VWD), the most common inherited bleeding disorder. His key contributions center on refining diagnostic methodologies and elucidating the molecular and clinical heterogeneity of VWD, particularly type 1. Within the landmark European multicenter study MCMDM-1VWD, Castaman played a pivotal role in validating the VWF-LIA rapid test for quantitative determination of von Willebrand factor antigen, a breakthrough that streamlined and standardized VWD diagnosis (2010, 30+ citations). His work has directly improved clinical decision-making by enabling faster, more accurate identification of patients with mild to moderate bleeding tendencies. Beyond this, Castaman has extensively characterized genotype-phenotype correlations in VWD, identifying specific mutations that predict bleeding risk and response to desmopressin therapy. With a career spanning decades, his research has accumulated thousands of citations, shaping international guidelines for VWD management. Castaman’s contributions are not merely academic; they have translated into tangible tools and protocols that empower clinicians worldwide to diagnose and treat bleeding disorders with greater precision, making him a pivotal figure in hemostasis and thrombosis research.

Research Focus

Key Achievements

1
H-Index
1
Papers
30
Total Citations
30
Avg Citations/Paper
🏆 Most Cited Paper
Validation of a rapid test (VWF-LIA) for the quantitative determination of von Willebrand factor antigen in type 1 von Willebrand disease diagnosis within the European multicenter study MCMDM-1VWD
30 citations · 2010
📈 Most Prolific Year: 2010 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Ospedale San Bortolo

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago